関連する実験動画
Updated: Jun 30, 2026

05:24
Teratoma Generation in the Testis Capsule
Published on: November 7, 2011
精巣の生殖細胞がんは精巣の生殖細胞がんである
Alan Horwich1, Janet Shipley, Robert Huddart
1Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey SM2 5PT, UK. alan.horwich@icr.ac.uk
Lancet (London, England)
|March 7, 2006
まとめ
精巣の生殖細胞腫瘍 (TGCTs) は,高度に治癒可能な癌です. 進歩は,予後に応じて治療を調整し,予後が良い転移性非精液腫の化学療法を削減し,ステージI精液腫の放射線治療の代替案を提供することに焦点を当てています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 癌の治療薬について
背景:
- 精巣の生殖細胞腫瘍 (TGCTs) は,治癒可能な悪性腫瘍のモデルである.
- TGCTの分子生物学を理解すると,他のがん治療にも役立つかもしれません.
- マネジメントは,若い成人の長期的な毒性を考慮する必要があります.
研究 の 目的:
- 過去10年にわたってTGCTの理解と管理における最近の進歩を要約します.
- 予後重症度に基づく治療の攻撃性の調整を強調する.
- 共通のTGCTサブタイプの管理における変化をレビューする.
主な方法:
- 精巣の生殖細胞腫瘍の管理における最近の進展のレビュー.
- 転移性非セミノーマの化学療法プロトコルにおける変化の分析.
- ステージIセミノーマに対する補助放射線治療の代替案の評価.
主要な成果:
- 現在,予後が良い転移性非セミノーマでは,低濃度の化学療法が推奨されています.
- ステージIのセミノーマでは,補助放射線治療の代替手段が利用できます.
- 治療戦略は,ますます個々の患者の予後に応じて調整されています.
結論:
- 精巣の生殖細胞腫瘍は,高度に治癒可能な悪性腫瘍であり,治療のパラダイムが進化しています.
- 最近の進歩は,治療の強度と毒性を減らすことに焦点を当てています.
- 予後に基づくパーソナライズされた管理は,TGCTの結果を改善しています.
関連する概念動画
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

